A global meta-analysis of gonorrhoea and chlamydia prevalence among men who have sex with men from 2000 to 2022 DOI
Ella P Davies, Motoyuki Tsuboi, Jayne Evans

и другие.

International Journal of STD & AIDS, Год журнала: 2025, Номер unknown

Опубликована: Апрель 21, 2025

Introduction We conducted a global systematic review and meta-analysis of gonorrhoea chlamydia among men who have sex with (MSM) from 2000 to 2022. Methods searched four databases identify studies between 1 January 19 April 2022 that reported prevalence aetiological assays. extracted data, calculated point estimates, corrected then pooled them using random-effects models. stratified results by United Nations regions subgroup analyses established apriori. Results 172 met our inclusion criteria, providing 387 data points 57 countries. The overall for was 7.2% [95% CI: 6.0 8.5; 188 points; n = 347,253] 9.9% (95% 8.8 11.0; 190 342,799). For gonorrhoea, 2010 5.0% 3.7 6.5; 89 78,557) compared 9.3% (7.7–11.1; 99 268,696) 2011 2022, p < 0.001. chlamydia, 6.6% 5.4 7.9; 95 91,015) 13.6% (12.0–15.2; 251,784) Conclusion A holistic approach is needed reduce the curable STIs burden MSM.

Язык: Английский

A global meta-analysis of gonorrhoea and chlamydia prevalence among men who have sex with men from 2000 to 2022 DOI
Ella P Davies, Motoyuki Tsuboi, Jayne Evans

и другие.

International Journal of STD & AIDS, Год журнала: 2025, Номер unknown

Опубликована: Апрель 21, 2025

Introduction We conducted a global systematic review and meta-analysis of gonorrhoea chlamydia among men who have sex with (MSM) from 2000 to 2022. Methods searched four databases identify studies between 1 January 19 April 2022 that reported prevalence aetiological assays. extracted data, calculated point estimates, corrected then pooled them using random-effects models. stratified results by United Nations regions subgroup analyses established apriori. Results 172 met our inclusion criteria, providing 387 data points 57 countries. The overall for was 7.2% [95% CI: 6.0 8.5; 188 points; n = 347,253] 9.9% (95% 8.8 11.0; 190 342,799). For gonorrhoea, 2010 5.0% 3.7 6.5; 89 78,557) compared 9.3% (7.7–11.1; 99 268,696) 2011 2022, p < 0.001. chlamydia, 6.6% 5.4 7.9; 95 91,015) 13.6% (12.0–15.2; 251,784) Conclusion A holistic approach is needed reduce the curable STIs burden MSM.

Язык: Английский

Процитировано

0